March 2017 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2015/16 Invitation to Tender, dated 6 November 2015 and the 2016/17 Invitation to Tender, dated 3 November 2016.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website(external link).

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand (http://www.pgnz.org.nz/pharmacode(external link)) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines (http://www.nzulm.org.nz/sponsors(external link)). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2015/16 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2019

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current price New price Hospital Supply
Brand (Supplier)
DVLimit Listing date Hospital Supply Status date Brand (Supplier) affected by delisting
Piperacillin with tazobactam Inj 4 g with tazobactam 0.5 g vial; 10 vials $5.84 for 1 vial $38.00 for 10 vials PipTaz Sandoz (Sandoz) 1% 1 March 2018 1 May 2018 Hospira (Hospira)

2016/17 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2020

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date
Alfacalcidol* Cap 0.25 mcg; 100 capsules, blister pack $26.32 $26.32 One-Alpha (LEO Pharma) 1 June 2017 1 September 2017
Alfacalcidol* Cap 1 mcg; 100 capsules, blister pack $87.98 $87.98 One-Alpha (LEO Pharma) 1 June 2017 1 September 2017
Alfacalcidol* Oral drops 2 mcg per ml; 20 ml OP bottle $60.68 $60.68 One-Alpha (LEO Pharma) 1 June 2017 1 September 2017
Exemestane Tab 25 mg; 30 tablets, blister pack $14.50 $14.50 Pfizer Exemestane (Pfizer) 1 July 2017 1 October 2017
Levonorgestrel* Subdermal implant; 2 x 75 mg rods $133.65 $106.92 Jadelle (Bayer) 1 January 2018 1 April 2018
Morphine sulphate Inj 5 mg per ml, 1 ml ampoule; 5 ampoules $12.48 $6.27 DBL Morphine Sulphate (Pfizer) 1 July 2017 1 October 2017
Morphine sulphate Inj 10 mg per ml, 1 ml ampoule; 5 ampoules $9.09 $4.47 DBL Morphine Sulphate (Pfizer) 1 July 2017 1 October 2017
Morphine sulphate Inj 15 mg per ml, 1 ml ampoule; 5 ampoules $9.77 $4.76 DBL Morphine Sulphate (Pfizer) 1 July 2017 1 October 2017
Morphine sulphate Inj 30 mg per ml, 1 ml ampoule; 5 ampoules $12.43 $6.19 DBL Morphine Sulphate (Pfizer) 1 July 2017 1 October 2017
Paracetamol (split market)* Tab 500 mg (blister pack); 1000 tablets, blister pack $8.50 $7.12 Pharmacare (API) 1 August 2017 1 November 2017
Paracetamol (split market) Tab 500 mg (bottle pack); 1000 tablets, bottle $8.50 $6.32 Pharmacare (API) 1 August 2017 1 November 2017
Risperidone* Tab 0.5 mg; 60 tablets, blister pack $1.90 $1.86 Actavis (Actavis) 1 October 2017 1 January 2018
Risperidone* Tab 1 mg; 60 tablets, blister pack $2.10 $2.06 Actavis (Actavis) 1 October 2017 1 January 2018
Risperidone* Tab 2 mg; 60 tablets, blister pack $2.34 $2.29 Actavis (Actavis) 1 October 2017 1 January 2018
Risperidone* Tab 3 mg; 60 tablets, blister pack $2.55 $2.50 Actavis (Actavis) 1 October 2017 1 January 2018
Risperidone* Tab 4 mg; 60 tablets, blister pack $3.50 $3.43 Actavis (Actavis) 1 October 2017 1 January 2018
Risperidone Oral liq 1 mg per ml; 30 ml bottle $9.75 $7.66 Risperon (Mylan) 1 July 2017 1 October 2017
Sodium citro-tartrate Grans eff 4 g sachets; 28 sachets $2.93 $2.34 Ural (Aspen) 1 July 2017 1 October 2017
Tramadol hydrochloride* Tab sustained-release 100 mg; 20 tablets, blister pack $2.00 $1.55 Tramal SR 100 (Seqirus) 1 July 2017 1 October 2017
Tramadol hydrochloride* Tab sustained-release 150 mg; 20 tablets, blister pack $3.00 $2.10 Tramal SR 150 (Seqirus) 1 July 2017 1 October 2017
Tramadol hydrochloride* Tab sustained-release 200 mg; 20 tablets, blister pack $4.00 $2.75 Tramal SR 200 (Seqirus) 1 July 2017 1 October 2017
*These products will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b)(II) of the 2016/17 Invitation To Tender.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) Brand (Supplier) affected by reference pricing and delisting
Carvedilol Tab 6.25 mg; 60 tablets, blister pack $3.90 $2.24 Carvedilol Sandoz (Novartis) 1 October 2017 1 December 2017 1 March 2018 Dicarz (Mylan)
Carvedilol Tab 12.5 mg; 60 tablets, blister pack $5.10 $2.30 Carvedilol Sandoz (Novartis) 1 October 2017 1 December 2017 1 March 2018 Dicarz (Mylan)
Carvedilol Tab 25 mg; 60 tablets, blister pack $6.30 $2.95 Carvedilol Sandoz (Novartis) 1 October 2017 1 December 2017 1 March 2018 Dicarz (Mylan)
Clonidine1 Patch 2.5 mg, 100 mcg per day; 4 patches $12.80 $7.40 Mylan (Mylan) 1 July 2017 1 September 2017 1 December 2017 Catapres-TTS-1 (Boehringer)
Clonidine1 Patch 5 mg, 200 mcg per day; 4 patches $18.04 $10.04 Mylan (Mylan) 1 July 2017 1 September 2017 1 December 2017 Catapres-TTS-2 (Boehringer)
Clonidine1 Patch 7.5 mg, 300 mcg per day; 4 patches $22.68 $12.34 Mylan (Mylan) 1 July 2017 1 September 2017 1 December 2017 Catapres-TTS-3 (Boehringer)
Escitalopram Tab 10 mg; 28 tablets, blister pack $1.40 $1.11 Apo-Escitalopram (Apotex) 1 October 2017 1 December 2017 1 March 2018 Air Flow Products (Airflow)
Escitalopram Tab 20 mg; 28 tablets, blister pack $2.40 $1.90 Apo-Escitalopram (Apotex) 1 October 2017 1 December 2017 1 March 2018 Air Flow Products (Airflow)
Hyoscine N-butylbromide Tab 10 mg; 100 tablets, bottle $2.18 for 20 $8.75 Buscopan (Boehringer) 1 October 2017 1 December 2017 1 March 2018 Gastrosoothe (AFT)
Travoprost Eye drops 0.004%; 5 ml OP bottle $19.50 for 2.5 ml $7.30 Travopt (Mylan) 1 November 2017 1 January 2018 1 April 2018 Travatan (Pharmaco)
1Brand switch fee of $4.50 is payable for this product from 1 December 2017 until 1 March 2018.

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

CORRECTION to March 2017 tender notification: in bold and strikethrough

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current price New price Hospital Supply
Brand (Supplier)
DVLimit Listing date Hospital Supply Status date
Alfacalcidol* Cap 0.25 mcg; 100 capsules, blister pack $26.32 $26.32 One-Alpha (Leo Pharma) 1% 1 June 2017 1 August 2017
Alfacalcidol* Cap 1 mcg; 100 capsules, blister pack $87.98 $87.98 One-Alpha (Leo Pharma) 1% 1 June 2017 1 August 2017
Docetaxel Inj 10 mg per ml, 2 ml vial; 1 vial $13.70 $12.40 DBL Docetaxel (Pfizer) 1% 1 July 2017 1 September 2017
Docetaxel Inj 10 mg per ml, 8 ml vial; 1 vial $29.99 $26.95 DBL Docetaxel (Pfizer) 1% 1 July 2017 1 September 2017
Exemestane Tab 25 mg; 30 tablets, blister pack $14.50 $14.50 Pfizer Exemestane (Pfizer) 1% 1 July 2017 1 September 2017
Levonorgestrel* Subdermal implant; 2 x 75 mg rods $133.65 $106.92 Jadelle (Bayer) 1% 1 January 2018 1 March 2018
Morphine sulphate Inj 5 mg per ml, 1 ml ampoule; 5 ampoules $12.48 $6.27 DBL Morphine Sulphate (Pfizer) 1% 1 July 2017 1 September 2017
Morphine sulphate Inj 10 mg per ml, 1 ml ampoule; 5 ampoules $9.09 $4.47 DBL Morphine Sulphate (Pfizer) 1% 1 July 2017 1 September 2017
Morphine sulphate Inj 15 mg per ml, 1 ml ampoule; 5 ampoules $9.77 $4.76 DBL Morphine Sulphate (Pfizer) 1% 1 July 2017 1 September 2017
Morphine sulphate Inj 30 mg per ml, 1 ml ampoule; 5 ampoules $12.43 $6.19 DBL Morphine Sulphate (Pfizer) 1% 1 July 2017 1 September 2017
Risperidone* Tab 0.5 mg; 60 tablets, blister pack $1.90 $1.86 Actavis (Actavis) 1% 1 October 2017 1 December 2017
Risperidone* Tab 1 mg; 60 tablets, blister pack $2.10 $2.06 Actavis (Actavis) 1% 1 October 2017 1 December 2017
Risperidone* Tab 2 mg; 60 tablets, blister pack $2.34 $2.29 Actavis (Actavis) 1% 1 October 2017 1 December 2017
Risperidone* Tab 3 mg; 60 tablets, blister pack $2.55 $2.50 Actavis (Actavis) 1% 1 October 2017 1 December 2017
Risperidone* Tab 4 mg; 60 tablets, blister pack $3.50 $3.43 Actavis (Actavis) 1% 1 October 2017 1 December 2017
Risperidone Oral liq 1 mg per ml; 30 ml bottle $9.75 $7.66 Risperon (Mylan) 1% 1 October 2017
1 July 2017
1 December 2017
1 September 2017
Sodium citro-tartrate Grans eff 4 g sachets; 28 sachets $2.93 $2.34 Ural (Aspen) 1% 1 July 2017 1 September 2017
Tramadol hydrochloride* Tab sustained-release 100 mg; 20 tablets, blister pack $2.00 $1.55 Tramal SR 100 (Seqirus) 1% 1 July 2017 1 September 2017
Tramadol hydrochloride* Tab sustained-release 150 mg; 20 tablets, blister pack $3.00 $2.10 Tramal SR 150 (Seqirus) 1% 1 July 2017 1 September 2017
Tramadol hydrochloride* Tab sustained-release 200 mg; 20 tablets, blister pack $4.00 $2.75 Tramal SR 200 (Seqirus) 1% 1 July 2017 1 September 2017
Tramadol hydrochloride* Inj 50 mg per ml, 1 ml ampoule; 5 ampoules $4.50 $4.50 Tramal 50 (Seqirus) 1% 1 July 2017 1 September 2017
Tramadol hydrochloride* Inj 50 mg per ml, 2 ml ampoule; 5 ampoules $4.50 $4.50 Tramal 100 (Seqirus) 1% 1 July 2017 1 September 2017
*These products will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedules 6, clause 3.1 (b)(II) of the 2016/17 Invitation To Tender. 

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current price New price Hospital SupplyBrand (Supplier) DVLimit Listing date Hospital Supply Status date Brand (Supplier) affected by delisting
Carvedilol Tab 6.25 mg; 60 tablets, blister pack $3.90 $2.24 Carvedilol Sandoz (Novartis) 1% 1 October 2017 1 December 2017 Dicarz (Mylan)
Carvedilol Tab 12.5 mg; 60 tablets, blister pack $5.10 $2.30 Carvedilol Sandoz (Novartis) 1% 1 October 2017 1 December 2017 Dicarz (Mylan)
Carvedilol Tab 25 mg; 60 tablets, blister pack $6.30 $2.95 Carvedilol Sandoz (Novartis) 1% 1 October 2017 1 December 2017 Dicarz (Mylan)
Clonidine Patch 2.5 mg, 100 mcg per day; 4 patches $12.80 $7.40 Mylan (Mylan) 1% 1 July 2017 1 September 2017 Catapres-TTS-1 (Boehringer)
Clonidine Patch 5 mg, 200 mcg per day; 4 patches $18.04 $10.04 Mylan (Mylan) 1% 1 July 2017 1 September 2017 Catapres-TTS-2 (Boehringer)
Clonidine Patch 7.5 mg, 300 mcg per day; 4 patches $22.68 $12.34 Mylan (Mylan) 1% 1 July 2017 1 September 2017 Catapres-TTS-3 (Boehringer)
Escitalopram Tab 10 mg; 28 tablets, blister pack $1.40 $1.11 Apo-Escitalopram (Apotex) 1% 1 October 2017 1 December 2017 Air Flow Products (Airflow)
Escitalopram Tab 20 mg; 28 tablets, blister pack $2.40 $1.90 Apo-Escitalopram (Apotex) 1% 1 October 2017 1 December 2017 Air Flow Products (Airflow)
Hyoscine Butylbromide Tab 10 mg; 100 tablets, bottle $2.18 for 20 $8.75 Buscopan (Boehringer) 1% 1 October 2017 1 December 2017 Gastrosoothe (AFT)
Ropivacaine hydrochloride Inj 2 mg per ml, 100 ml; 5 bags $60.00 $29.50 Ropivacaine Kabi (Fresenius Kabi) 1% 1 May 2017
1 July 2017
1 July 2017
1 September 2017
Naropin (Aspen)
Ropivacaine hydrochloride Inj 2 mg per ml, 200 ml; 5 bags $79.50 $39.00 Ropivacaine Kabi (Fresenius Kabi) 1% 1 May 2017
1 July 2017
1 July 2017
1 September 2017
Naropin (Aspen)

Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Pack Price Hospital Supply
Brand (Supplier)
DVLimit Listing date Hospital Supply Status date
Alfacalcidol* Oral drops 2 mcg per ml; 20 ml bottle $60.68 One-Alpha (Leo Pharma) 1% 1 June 2017 1 August 2017
Travoprost Eye drops 0.004%; 5 ml bottle $7.30 Travopt (Mylan) 1% 1 November 2017 1 January 2018

*This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedules 6, clause 3.1 (b)(II) of the 2016/17 Invitation To Tender.

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2016/17 Invitation to Tender, dated 3 November 2016:

2016/17 Invitation to Tender

Chemical Name Line Item

Acetazolamide

Inj 500 mg

Amikacin

Inj

Artemether with lumefantrine

Tab 20 mg with lumefantrine 120 mg

Aztreonam

Inj 1 g

Betamethasone valerate with clioquinol

Crm 0.1% with clioquinol 3%

Betaxolol hydrochloride

Eye drops 0.25%

Betaxolol hydrochloride

Eye drops 0.5%

Calcipotriol

Crm 50 mcg per g

Calcium folinate

Inj 3 mg

Calcium folinate

Inj 300 mg

Carmellose sodium with gelatin and pectin

Paste

Carmellose sodium with gelatin and pectin

Powder

Chloroquine phosphate

Tab 250 mg

Clofazimine

Cap 50 mg

Dapsone

Tab 100 mg

Dapsone

Tab 25 mg

Dexamethasone with tobramycin

Eye drops 0.1% with tobramycin 0.3%

Diclofenac Sodium

Eye drops 1 mg per ml, 5 ml

Ezetimibe with simvastatin

Tab 10 mg with simvastatin 20 mg

Ezetimibe with simvastatin

Tab 10 mg with simvastatin 40 mg

Ezetimibe with simvastatin

Tab 10 mg with simvastatin 80 mg

Ezetimibe with simvastatin

Tab 10 mg with simvastatin 10 mg

Flucloxacillin Sodium

Inj 2 g

Ibuprofen

Inj 10 mg per ml, 2 ml

Ibuprofen

Inj 5 mg per ml, 2 ml

Isotretinoin

Cap 5 mg

Itraconazole

Oral liq 10 mg per ml

Levomepromazine

Tab 25 mg

Levomepromazine

Tab 100 mg

Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride

Powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg (electrolyte free)

Methylprednisolone aceponate

Crm 0.1%

Methylprednisolone aceponate

Oint 0.1%

Naphazoline hydrochloride

Eye drops 0.1%

Nitrofurantoin

Tab modified-release 50 mg

Paracetamol

Tab 500 mg (pack size of 100 or less)

Paracetamol

Tab soluble 500 mg

Paracetamol (combined market)

Tab 500 mg

Pentamidine isethionate

Inj 300 mg

Pilocarpine hydrochloride

Eye drops 1%

Pilocarpine hydrochloride

Eye drops 2%

Pilocarpine hydrochloride

Eye drops 4%

Povidone Iodine

Oint 10 %

Praziquantel

Tab 600 mg

Rifampicin

Tab 600 mg

Risperidone

Inj 25 mg per 2 ml

Risperidone

Inj 37.5 mg per 2 ml

Risperidone

Inj 50 mg per 2 ml

Ritonavir

Tab 100 mg

Tobramycin

Inj 100 mg per ml, 5 ml

Tobramycin

Powder BP

Tropicamide

Eye drops 0.5%

Tropicamide

Eye drops 1%

For products included in the 2014/15, 2015/16 and 2016/17 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. 

If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.